We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Relypsa’s Novel Potassium-Lowering Drug Veltassa
FDA Approves Relypsa’s Novel Potassium-Lowering Drug Veltassa
The FDA Wednesday approved Relypsa’s hyperkalemia therapy Veltassa — the company’s first product and the first advance in treating the life-threatening condition in more than five decades.